Cellebrite DI Ltd. (CLBT) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts CLBT Hot Sheet
Join SI Premium – FREE
Cellebrite DI Ltd. (NASDAQ: CLBT) reported Q3 EPS of $0.14, $0.05 better than the analyst estimate of $0.09. Revenue for the quarter came in at $126 million versus the consensus estimate of $122.98 million.
GUIDANCE:
Cellebrite DI Ltd. sees Q4 2025 revenue of $123-128 million, versus the consensus of $125 million.
For earnings history and earnings-related data on Cellebrite DI Ltd. (CLBT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- First Tracks Biotherapeutics, Inc. (TRAX) Misses Q3 EPS by 88c
- Amdocs (DOX) Reports In-Line Q4 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
